The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer

PURPOSE: Breast cancer (BC) is a heterogeneous disease consisting of various subtypes, with different prognostic and therapeutic outcomes. The amino acid transporter, SLC7A8, is overexpressed in oestrogen receptor-positive BC. However, the consequence of this overexpression, in terms of disease prog...

Descripción completa

Detalles Bibliográficos
Autores principales: El Ansari, Rokaya, Alfarsi, Lutfi, Craze, Madeleine L., Masisi, Brendah K., Ellis, Ian O., Rakha, Emad A., Green, Andrew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182634/
https://www.ncbi.nlm.nih.gov/pubmed/32200487
http://dx.doi.org/10.1007/s10549-020-05586-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182634/
https://www.ncbi.nlm.nih.gov/pubmed/32200487
http://dx.doi.org/10.1007/s10549-020-05586-6

Ejemplares similares